Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.4K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.4K
Standard Precaution01:26

Standard Precaution

2.6K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.6K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

329
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
329
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

5.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.3K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

361
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
361

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of institutional guideline adherence for carbapenem use at a large academic medical center.

Infectious diseases (London, England)·2017
Same author

Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia.

Infectious diseases (London, England)·2015
Same author

Risk of Clostridium difficile infection in intensive care unit patients with sepsis exposed to metronidazole.

Infectious diseases (London, England)·2015
Same author

Salmonella aortitis treated with endovascular aortic repair.

Annals of vascular surgery·2013
Same author

Treatment of endocarditis due to Proteus species: a literature review.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2011
Same author

Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens.

Critical care clinics·2010

Related Experiment Video

Updated: Dec 19, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.5K

Recurrent Clostridioides difficile infection: Recognition, management, prevention.

Constantine Tsigrelis1

  • 1Department of Infectious Disease, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH tsigrec@ccf.org.

Cleveland Clinic Journal of Medicine
|June 4, 2020
PubMed
Summary

Clostridioides difficile infection (CDI) causes significant issues in hospitals, often recurring after antibiotic treatment. New strategies are needed to manage and prevent these difficult-to-treat recurrent infections.

More Related Videos

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.7K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

Related Experiment Videos

Last Updated: Dec 19, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.7K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Gastroenterology

Background:

  • Clostridioides difficile infection (CDI) is a leading cause of hospital-acquired diarrhea.
  • Current antibiotic treatments for CDI are frequently complicated by recurrent infections.
  • Recurrent CDI poses significant morbidity, mortality, and economic burdens.

Purpose of the Study:

  • To highlight the challenges in managing recurrent Clostridioides difficile infection.
  • To emphasize the need for improved diagnostic and therapeutic strategies.
  • To address the impact of antibiotic-induced microbiota disruption on CDI recurrence.

Main Methods:

  • Review of existing literature on CDI pathogenesis and treatment.
  • Analysis of factors contributing to recurrent CDI episodes.
  • Examination of current clinical management guidelines and their limitations.

Main Results:

  • Antibiotic use disrupts the colonic microbiota, increasing the risk of recurrent CDI.
  • Recurrence risk escalates after the initial CDI episode.
  • Timely diagnosis and targeted interventions are crucial for preventing complications.

Conclusions:

  • Effective management of recurrent CDI requires strategies beyond standard antibiotic therapy.
  • Understanding microbiota dynamics is key to preventing CDI relapse.
  • Further research into novel treatments and preventative measures is warranted.